BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36626416)

  • 21. Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study.
    Xie C; Chen Z; Xu J; Meng Z; Huang Z; Lin J
    PeerJ; 2022; 10():e12974. PubMed ID: 35256918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
    Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
    Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma.
    Wang Z; Chen P; Wang F; Lin L; Liu S
    Thorac Cancer; 2019 Feb; 10(2):150-155. PubMed ID: 30484962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma.
    Takahashi K; Hashimoto S; Mizuno KI; Kobayashi T; Tominaga K; Sato H; Kohisa J; Ikarashi S; Hayashi K; Takeuchi M; Yokoyama J; Kawai H; Sato Y; Kobayashi M; Terai S
    Endoscopy; 2018 Jul; 50(7):662-670. PubMed ID: 29272907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma.
    Shigeno T; Hoshino A; Matsunaga S; Shimano R; Ishibashi N; Shinohara H; Shiobara H; Tomii C; Saito K; Fujiwara N; Sato Y; Kawada K; Tokunaga M; Kinugasa Y
    BMC Surg; 2022 May; 22(1):171. PubMed ID: 35545769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Submucosal Saline Injection Followed by Endoscopic Ultrasound versus Endoscopic Ultrasound Only for Distinguishing between T1a and T1b Esophageal Cancer.
    He LJ; Xie C; Wang ZX; Li Y; Xiao YT; Gao XY; Shan HB; Luo LN; Chen LM; Luo GY; Yang P; Zeng SC; Xu GL; Li JJ
    Clin Cancer Res; 2020 Jan; 26(2):384-390. PubMed ID: 31615934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
    Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K; Makuuchi H; Ogura G
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30883635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion.
    Sato D; Kadota T; Inaba A; Nishihara K; Takashima K; Nakajo K; Sawada K; Kotani D; Fujiwara H; Yoda Y; Kojima T; Fujita T; Fujii S; Yano T
    Gastrointest Endosc; 2022 Apr; 95(4):634-641.e3. PubMed ID: 34774578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma.
    Huang Q; Luo K; Chen C; Wang G; Jin J; Kong M; Li B; Liu Q; Li J; Rong T; Chen H; Zhang L; Chen Y; Zhu C; Zheng B; Wen J; Zheng Y; Tan Z; Xie X; Yang H; Fu J
    J Thorac Oncol; 2016 Apr; 11(4):583-92. PubMed ID: 26792626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative parameters derived from dual-energy computed tomography for the preoperative prediction of early recurrence in patients with esophageal squamous cell carcinoma.
    Liu Y; Cheng F; Wang L; Du L; Shen H; Wang X; Zeng Z; Liu D; Tao J; Wu J; Zhang J
    Eur Radiol; 2023 Nov; 33(11):7419-7428. PubMed ID: 37314470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
    Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of endoscopic submucosal dissection with additional radiotherapy for T1a-MM/T1b-SM esophageal squamous cell carcinoma].
    Chen YF; Liu SQ; Li MY; Chen R; Shi RH
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3676-3682. PubMed ID: 38018068
    [No Abstract]   [Full Text] [Related]  

  • 37. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy.
    Kurokawa T; Hamai Y; Emi M; Ibuki Y; Yoshikawa T; Ohsawa M; Hirohata R; Okada M
    Anticancer Res; 2020 Aug; 40(8):4387-4394. PubMed ID: 32727767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic resection with adjuvant treatment versus esophagectomy for early-stage esophageal cancer.
    Huang B; Xu MC; Pennathur A; Li Z; Liu Z; Wu Q; Wang J; Luo K; Bai J; Wei Z; Xiang J; Fang W; Zhang J
    Surg Endosc; 2022 Mar; 36(3):1868-1875. PubMed ID: 33893544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SUV
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    World J Surg Oncol; 2021 Apr; 19(1):105. PubMed ID: 33836789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.